Physician

Michael Weston Hines, MD

According to 2025 Medicare claims, Michael Hines, MD (NPI: 1619951803) practices ophthalmology in the Ocala, FL market, with the plurality of this provider's patient population coming from Marion, FL. This provider's primary affiliated billing organization is RETINA CENTER PA (NPI: 1477537645; TIN: 59-3192481) and primary practice location at 32605-6603.

Hines' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 617 traditional Medicare patients, billed 8,209 HCPCS/CPT codes, and received $910,573 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 793 prescription claims across 167 beneficiaries totaling $623,282 in drug costs, led by Eylea (Aflibercept). Open Payments data shows 1 records totaling $20. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $441,469 to $910,573. Similarly, Part D prescription costs have risen steadily, from $62,630 to $623,282. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$455K$911K2015 Medicare payment: $441,469 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $397,682 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $354,653 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $365,703 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $343,336 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $274,295 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $261,028 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $253,376 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $628,101 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $910,573 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20159055,981$441,469
20168966,132$397,682
20178725,889$354,653
20187895,559$365,703
20198075,459$343,336
20206344,292$274,295
20216524,024$261,028
20226503,710$253,376
20236095,895$628,101
20246178,209$910,573

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$312K$623K2015 Drug cost: $62,630 (USD; Tot_Drug_Cst)2016 Drug cost: $46,035 (USD; Tot_Drug_Cst)2017 Drug cost: $49,031 (USD; Tot_Drug_Cst)2018 Drug cost: $220,178 (USD; Tot_Drug_Cst)2019 Drug cost: $302,049 (USD; Tot_Drug_Cst)2020 Drug cost: $318,954 (USD; Tot_Drug_Cst)2021 Drug cost: $238,561 (USD; Tot_Drug_Cst)2022 Drug cost: $423,380 (USD; Tot_Drug_Cst)2023 Drug cost: $428,582 (USD; Tot_Drug_Cst)2024 Drug cost: $623,282 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201571249$62,630
201663212$46,035
201760239$49,031
201883336$220,178
2019162525$302,049
2020126495$318,954
2021124486$238,561
2022127517$423,380
2023156696$428,582
2024167793$623,282

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more120120$113
92014Established patient complete exam of visual system425629$84
67028Injection of drug into eye170972$81
J3490Unclassified drugs117461$62
92134Imaging of retina5441,350$29

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EyleaAflibercept1394,022$469,728
SyfovrePegcetacoplan/Pf26734$86,449
VabysmoFaricimab-Svoa16457$39,970
Prednisolone AcetatePrednisolone Acetate1644,479$6,348
Atropine SulfateAtropine Sulfate1193,868$3,965

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$20Astellas Pharma US Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Michael Weston Hines, MD?

Tedicare shows public-source Medicare data for Michael Weston Hines, MD (NPI 1619951803), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Weston Hines, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michael Weston Hines, MD?

Michael Weston Hines, MD is linked to RETINA CENTER PA (billing NPI 1477537645) in the available physician profile data.

Does Michael Weston Hines, MD have Open Payments data?

Michael Weston Hines, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.